The utility of syndecan-1 circulating levels as a biomarker in patients with previous or active COVID-19: a systematic review and meta-analysis.

Saved in:
Bibliographic Details
Title: The utility of syndecan-1 circulating levels as a biomarker in patients with previous or active COVID-19: a systematic review and meta-analysis.
Authors: Ghondaghsaz E; Undergraduate Program in Neuroscience, University of British Columbia, Vancouver, BC, Canada., Khalaji A; School of Medicine, Tehran University of Medical Sciences, Poursina St., Keshavarz Blvd, Tehran, 1417613151, Iran., Norouzi M; Faculty of Life Sciences and Biotechnology, Shahid Beheshti University, Tehran, Iran., Fraser DD; Children's Health Research Institute, London, ON, Canada.; Lawson Health Research Institute, London, ON, Canada.; Department of Pediatrics, Western University, London, ON, Canada.; Department of Physiology & Pharmacology, Western University, London, ON, Canada.; Department of Clinical Neurological Sciences, Western University, London, ON, Canada., Alilou S; School of Medicine, Iran University of Medical Sciences, Tehran, Iran., Behnoush AH; School of Medicine, Tehran University of Medical Sciences, Poursina St., Keshavarz Blvd, Tehran, 1417613151, Iran. amirhossein.behnoush@gmail.com.
Source: BMC infectious diseases [BMC Infect Dis] 2023 Aug 04; Vol. 23 (1), pp. 510. Date of Electronic Publication: 2023 Aug 04.
Publication Type: Meta-Analysis; Systematic Review; Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334 (Electronic) Linking ISSN: 14712334 NLM ISO Abbreviation: BMC Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first